Hypertriglyceridemia

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

By

Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.

LDL Cholesterol, Triglyceride Reductions in Hypertriglyceridemia Vary by Statin

LDL Cholesterol, Triglyceride Reductions in Hypertriglyceridemia Vary by Statin

Greater LDL cholesterol reductions for rosuvastatin 10 mg to 40 mg vs equal and double doses of atorvastatin and simvastatin.

Sign Up for Free e-Newsletters



CME Focus